A functional role for complex gangliosides: Motor deficits in GM2/GD2 synthase knockout mice

Experimental Neurology

Volumn 166, Issue 2, 2000, Pages 227-234

  Chiavegatto, Silvana ^a,b   Sun, Ji ^b   Nelson, Randy J ^a,b   Schnaar, Ronald L ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Ataxia; Axonal degeneration; Balance; Coordina tion; Dysmyelination; Gangliosides; Gene knockout; Glycosphingolipids; Locomotion; Tremor

Indexed keywords

GANGLIOSIDE GD2; GANGLIOSIDE GM2; SYNTHETASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; CATALEPSY; CONTROLLED STUDY; COORDINATION; DEGENERATIVE DISEASE; GAIT DISORDER; KNOCKOUT MOUSE; LOCOMOTION; MOTOR DYSFUNCTION; MOUSE; MUSCLE STRENGTH; MYELIN DEFICIENCY; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROPRIOCEPTION; REFLEX; TREMOR;

EID: 0033673678     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7504     Document Type: Article

References (39)

1. Effects of single and long-term haloperidol administration on open field behavior of rats
2. Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L- 701,324 or the MAO-B inhibitor R(-)-deprenyl
3. Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin
4. Sialic acid specificity of myelin-associated glycoprotein binding
5. On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity
6. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents
7. Glycosphingolipids that can regulate nerve growth and repair
8. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis
9. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks
10. Deficient ganglioside biosynthesis: A novel human sphingolipidosis
11. Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment
12. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity
13. Bifunctional role of glycosphingolipids: Modulators for transmembrane signaling and mediators for cellular interactions
14. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome
15. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse
16. Motor function analysis of myelin mutant mice using a rotarod
17. Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats
18. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder
19. GM3 (hematoside) sphingolipodystrophy
20. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration
21. Sialic acid binding receptors (siglecs) expressed by macrophages
22. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways
23. Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test
24. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
25. Glycosphingolipids in cell surface recognition
26. Molecular mimicry in Guillain-Barre syndrome
27. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects
28. Glycosphingolipids: Structure, biological source, and properties
29. Gangliosides and synaptic transmission
30. Designation and schematic structure of gangliosides and allied glycosphingolipids
31. Ganglioside loss is a primary event in Alzheimer disease type I
32. A procedure for the quantitative isolation of brain gangliosides
33. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system
34. A new procedure for the extraction, purification and fractionation of brain gangliosides
35. The beta-hexosaminidase deficiency disorders: Development of a clinical paradigm in the mouse
36. Sialic acids as ligands in recognition phenomena
37. Gangliosides are neuronal ligands for myelin-associated glycoprotein
38. Haloperidol catalepsy in grouped and isolated mice